Antioch, K.M., Ellis, R.P., Gillett, S., Borovnicar, D., Marshall, R.P.: Risk adjustment policy options for casemix funding: international lessons in financing reform. Eur. J. Health Econ. 8, 195-212 (2007).
- Beebe, J.C. :An Outlier Pool for Medicare HMO Payments. Health Care Financing Review 14(1):59-63 (1992).
Paper not yet in RePEc: Add citation now
Behrend, C., Buchner, F., Happich, M., Holle, R., Reitmeir, P., Wasem, J.: Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set. Eur. J. Health Econ. 8,31-39(2007).
Buchner, F., Wasem, J. Needs for Further Improvement: Risk Adjustment in the German Health Insurance System. Health Policy 2003;65: 21-35.
Cutler, D.M., Landrum, M.N., Stewart, K.A.: Intensive medical care and cardiovascular disease disability reductions. NBER Working Paper 12184 (2006).
Ellis, R.P., McGuire, T.G.: Insurance Principles and the Design of Prospective Payment Systems. Journal of Health Economics 7:21 5-237 (1988).
- Ettner, S.L., Frank, R.G., McGuire, T.G., Hermann, R.C.: Risk adjustment alternatives in paying for behavioral health care under Medicaid. Health Services Research 36:793-811 (2001).
Paper not yet in RePEc: Add citation now
Garcia-Goñi, M., Ibern, P.: Predictability of drug expenditures: an application using morbiditydata. Health Economics 17(1): 119-126 (2008).
- Garcia-Goñi, M.: El Ajuste de Riesgos en los mercados sanitarios; Experiencias Europeas. In IntegraciOn asistencial: fundamentos, experiencias y vIas de avance, edited by P. I bern, pp. 187-208. Barcelona, Spain: Masson (2006).
Paper not yet in RePEc: Add citation now
- Garcia-Sempere, A., PeirO, S.: Gasto farmacéutico en atenciOn primaria: variables asociadas y asignaciOn de presupuestos de farmacia por zonas de salud. Gaceta Sanitaria 15:32-40 (2001).
Paper not yet in RePEc: Add citation now
Healey, A.T., Yule, B.F., Reid, J.P.: Variation in general practice prescribing costs and implications for budget setting. Health Economics 3(1):1-47 (1994).
- Hughes, J.S., Averill, R.F., Eisenhandler, J., Goldfield, NI., Muldoon, J., Neff, J.M., Gay, J.C.: Clinical Risk Groups (CRG5): a classification system for risk-adjusted capitationbased payment and health care management. Medical Care 42(1):81-90 (2004).
Paper not yet in RePEc: Add citation now
- Ibern, P, Inoriza, JM.: La despesa farmaceutica segons morbiditat. Cap.5 en Estudis dEconomia de Ia Salut. General itat de Catalunya, Departement de Salut, Barcelona. 111-
Paper not yet in RePEc: Add citation now
- Inoriza, J.M., Coderch-Lassaletta, J., Carreras, M., Vall.llosera, L., Ibern, P., GarcIa-Goñi, M., Lisbona, J.M.: La medida de Ia morbilidad atendida en una organización sanitaria integrada. Gaceta Sanitaria 22:1 - 11(2008).
Paper not yet in RePEc: Add citation now
Keeler, E.B., Carter, T.: Insurance Aspects of DRG Outlier Payments. Journal of Health Economics 7:193-214 (1988).
- Lamers, L.M., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M. Risk Adjusted Premium Subsidies and Risk Sharing: Key Elements of the Competitive Sickness Fund Market in the Netherlands. Health Policy 2003;65: 49-62.
Paper not yet in RePEc: Add citation now
- Luft, H.S., Dudley, R.A.: Assessing Risk Adjustment Approaches under Non-Random Selection. Inquiry 41:203-217 (2004).
Paper not yet in RePEc: Add citation now
- Morgan, 5G.: Prescription Drug Expenditures and Population Demographics. Health Services Research 41 (2):41 1-428 (2006).
Paper not yet in RePEc: Add citation now
Newhouse, J.P.: Reimbursing Health Plans and Health Providers: Efficiency in Production versus Selection. Journal of Economic Literature 34:1236-1 263 (1996).
Rice, N., Dixon, P., Lloyd, D.C., Roberts, D.: Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis. British Medical Journal 320: 284-288 (2000).
- Robinson, J.W.: Regression Tree Boosting to Adjust Health Care Cost Predictions for Diagnostic Mix. Health Services Research (OnlineEarly Articles) doi:1 0.111 1/j.1 475-6773.2007.00761 .x (2007).
Paper not yet in RePEc: Add citation now
- Rosen, A.B., Hamel, MB., Weinstein, MC., Cutler, D.M., Fendrick, AM, Vijan. S.: Costeffectiveness of full medicare coverage of angiotensing-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med 143(2) 89-99 (2005).
Paper not yet in RePEc: Add citation now
Schokkaert, E., Van de Voorde, C. Belgium: Risk Adjustment and Financial Responsibility in a Centralised System. Health Policy 2003;65: 5-19.
- Thomas, J.W.: Should Episode-Based Economic Profiles Be Risk Adjusted to Account for Differences in Patients Health Risks?. Health Services Research 41(2):581-598 (2006).
Paper not yet in RePEc: Add citation now
- Van Barneveld, E.M.: Risk sharing as a supplement to imperfect capitation in health insurance: a tradeoff between selection and efficiency. Doctoral dissertation. Erasmus University Rotterdam (2000).
Paper not yet in RePEc: Add citation now
- Van Barneveld, EM., Lamers, L.M., Van Vliet, R.C.J.A, Van de Ven, W.P.M.M.: Mandatory Pooling as a Supplement to Risk-Adjustment Capitation Payments in a Competitive Health Insurance Market. Social Science and Medicine 47:223-232 (1997).
Paper not yet in RePEc: Add citation now
Van Barneveld, EM., Lamers, L.M., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Risk Sharing as a Supplement to Imperfect Capitation in Health Insurance: a Tradeoff Between Selection and Efficiency. Journal of Health Economics 20:1 47-1 68 (2001).
- Van de Ven, W.P.M.M., Beck, K., et al. Risk Adjustment and Risk Selection on the Sickness Fund Insurance Market in Five European Countries. Health Policy 2003;65: 75-
Paper not yet in RePEc: Add citation now
Van de Ven, W.P.M.M., Ellis, R.P.: Risk adjustment in Competitive Health Plan Markets. In Handbook of Health Economics, edited by A.J. Culyer and J.P. Newhouse. Amsterdam, The Netherlands: Elsevier (2000).
Van de Ven, W.P.M.M., Van Vliet, R.C.J.A., Schut, E., Van Barneveld, E.M.: Access Coverage for High-Risks in a Competitive Individual Health Insurance Market: Via Premium Rate Restrictions or Risk-Adjustment Premium Subsidies?. Journal of Health Economics 19:311-339 (2000).
- Winkelman, R., Mehmud, S.A.: A Comparative Analysis of Claims-Based Tools for Health Risk Assessment. Society of Actuaries sponsored Research Project [accessed on July 21, 2007]. Available at: httQ://www.soa.org/soaweb!f es/Qdf/hsk~assessmentc.~df (2007).
Paper not yet in RePEc: Add citation now
- Wrobel, MV., Doshi, J., Stuart, B.C., Briesacher, B.: Predictability of prescription drug expenditures for Medicare beneficiaries. Health Care Financing Review 25(2):37-46 (2003).
Paper not yet in RePEc: Add citation now
- Zhao, Y., Ash, AS., Ellis, R.P., Ayanian, J.Z., Pope, G.C., Bowen, B., Weyuker, L.: Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Medical Care 43(1):34-43 (2005).
Paper not yet in RePEc: Add citation now
- Zhao, Y., Ellis, R.P., Ash, AS., Calabrese, D., Ayanian, J.Z., Slaughter, J.P., Weyuker, L., Bowen, B.: Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Services Research 36:1 80-93 (2001).
Paper not yet in RePEc: Add citation now
- Zuvekas, S.H., Cohen, J.W.: Prescription Drugs And The Changing Concentration Of Health Care Expenditures. Health Affairs 26(1):249-257 (2007).
Paper not yet in RePEc: Add citation now